Bortezomib in Treating Patients With Newly Diagnosed Multiple Myeloma
type: MedicalStudy
description: Phase II Study of PS-341 for Patients With High-Risk, Newly Diagnosed Multiple Myeloma
status: COMPLETED
study design: INTERVENTIONAL
phase: PHASE2
start date: 2004-01
end date: 2012-10
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT00075881
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: National Cancer Institute (NCI)
study subject: Stage I Multiple Myeloma
study subject: Stage II Multiple Myeloma
study subject: Stage III Multiple Myeloma
keywords: PHASE2
keywords: INTERVENTIONAL
keywords: COMPLETED
keywords: Stage I Multiple Myeloma
keywords: Stage II Multiple Myeloma
keywords: Stage III Multiple Myeloma

AI Analytics
type: Organization